Circ_0072008, an oncogene in pancreatic ductal adenocarcinoma, contributes to tumour cell malignant progression and glycolysis by regulating miR-545-3p/SLC7A11 axis

References

• Amundadottir LT. Pancreatic cancer genetics. Int J Biol Sci. 2016;12(3):314–325.
   PubMed Web of Science ®Google Scholar
• Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10(1):10–27.
   PubMedGoogle Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Cameron ME, Yakovenko A, Trevino JG. Glucose and lactate transport in pancreatic cancer: glycolytic metabolism revisited. J Oncol. 2018;2018:6214838.
   PubMed Web of Science ®Google Scholar
• Yan L, Raj P, Yao W, et al. Glucose metabolism in pancreatic cancer. Cancers. 2019;11(10):1460.
   Web of Science ®Google Scholar
• Yang J, Ren B, Yang G, et al. The enhancement of glycolysis regulates pancreatic cancer metastasis. Cell Mol Life Sci. 2020;77(2):305–321.
   PubMed Web of Science ®Google Scholar
• Cubuk C, Hidalgo MR, Amadoz A, et al. Gene expression integration into pathway modules reveals a Pan-cancer metabolic landscape. Cancer Res. 2018;78(21):6059–6072.
   PubMed Web of Science ®Google Scholar
• Yu T, Wang Y, Fan Y, et al. CircRNAs in cancer metabolism: a review. J Hematol Oncol. 2019;12(1):90.
   PubMed Web of Science ®Google Scholar
• Liu H, Luo J, Luan S, et al. Long non-coding RNAs involved in cancer metabolic reprogramming. Cell Mol Life Sci. 2019;76(3):495–504.
   PubMed Web of Science ®Google Scholar
• Capula M, Mantini G, Funel N, et al. New avenues in pancreatic cancer: exploiting microRNAs as predictive biomarkers and new approaches to target aberrant metabolism. Expert Rev Clin Pharmacol. 2019;12(12):1081–1090.
   PubMed Web of Science ®Google Scholar
• Qu S, Yang X, Li X, et al. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365(2):141–148.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang F, Wu D, et al. A novel circ_0099999/miR-330-5p/FSCN1 ceRNA crosstalk in pancreatic cancer. Autoimmunity. 2021;54(7):471–482.
   PubMed Web of Science ®Google Scholar
• Wang S, Feng X, Wang Y, et al. Dysregulation of tumour microenvironment driven by circ-TPGS2/miR-7/TRAF6/NF-κB axis facilitates breast cancer cell motility. Autoimmunity. 2021;54(5):284–293.
   PubMed Web of Science ®Google Scholar
• Zhang R, Shang L, Nan J, et al. Circ-METTL15 contributes to the proliferation, metastasis, immune escape and restrains apoptosis in lung cancer by regulating miR-1299/PDL1 axis. Autoimmunity. 2021;19:1–13.
   Google Scholar
• Yuan G, Wu H, Du Y, et al. Tumor suppressor role of microRNA-545 in oral squamous cell carcinoma. Oncol Lett. 2019;17(2):2063–2068.
   PubMed Web of Science ®Google Scholar
• Huang X, Lu S. MicroR-545 mediates colorectal cancer cells proliferation through up-regulating epidermal growth factor receptor expression in HOTAIR long non-coding RNA dependent. Mol Cell Biochem. 2017;431(1–2):45–54.
   PubMed Web of Science ®Google Scholar
• Changjun L, Feizhou H, Dezhen P, et al. MiR-545-3p/MT1M axis regulates cell proliferation, invasion and migration in hepatocellular carcinoma. Biomed Pharmacother. 2018;108:347–354.
   PubMed Web of Science ®Google Scholar
• Lewerenz J, Hewett SJ, Huang Y, et al. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013;18(5):522–555.
   PubMed Web of Science ®Google Scholar
• Koppula P, Zhang Y, Shi J, et al. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate. J Biol Chem. 2017;292(34):14240–14249.
   PubMed Web of Science ®Google Scholar
• Daher B, Parks SK, Durivault J, et al. Genetic ablation of the cystine transporter xCT in PDAC cells inhibits mTORC1, growth, survival, and tumor formation via nutrient and oxidative stresses. Cancer Res. 2019;79(15):3877–3890.
   PubMed Web of Science ®Google Scholar
• Lo M, Ling V, Wang YZ, et al. The xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance. Br J Cancer. 2008;99(3):464–472.
   PubMed Web of Science ®Google Scholar
• Schmidt CA, Fisher-Wellman KH, Neufer PD. From OCR and ECAR to energy: perspectives on the design and interpretation of bioenergetics studies. J Biol Chem. 2021;297(4):101140.
   PubMed Web of Science ®Google Scholar
• Dranka BP, Benavides GA, Diers AR, et al. Assessing bioenergetic function in response to oxidative stress by metabolic profiling. Free Radic Biol Med. 2011;51(9):1621–1635.
   PubMed Web of Science ®Google Scholar
• Qian W, Van Houten B. Alterations in bioenergetics due to changes in mitochondrial DNA copy number. Methods. 2010;51(4):452–457.
   PubMed Web of Science ®Google Scholar
• Zhang J, Gao Q, Zhou Y, et al. Focal adhesion kinase-promoted tumor glucose metabolism is associated with a shift of mitochondrial respiration to glycolysis. Oncogene. 2016;35(15):1926–1942.
   PubMed Web of Science ®Google Scholar
• Liang L, Zhang L, Zhang J, et al. Identification of circRNA-miRNA-mRNA networks for exploring the fundamental mechanism in lung adenocarcinoma. Onco Targets Ther. 2020;13:2945–2955.
   PubMed Web of Science ®Google Scholar
• Zhan W, Liao X, Chen Z, et al. Circular RNA hsa_circRNA_103809 promoted hepatocellular carcinoma development by regulating miR-377-3p/FGFR1/ERK axis. J Cell Physiol. 2020;235(2):1733–1745.
   PubMed Web of Science ®Google Scholar
• Tao T, Yuan S, Liu J, et al. Cancer stem cell-specific expression profiles reveal emerging bladder cancer biomarkers and identify circRNA_103809 as an important regulator in bladder cancer. Aging (Albany NY). 2020;12(4):3354–3370.
   PubMedGoogle Scholar
• Li H, Hao X, Wang H, et al. Circular RNA expression profile of pancreatic ductal adenocarcinoma revealed by microarray. Cell Physiol Biochem. 2016;40(6):1334–1344.
   PubMed Web of Science ®Google Scholar
• Liu W, Ma W, Yuan Y, et al. Circular RNA hsa_circRNA_103809 promotes lung cancer progression via facilitating ZNF121-dependent MYC expression by sequestering miR-4302. Biochem Biophys Res Commun. 2018;500(4):846–851.
   PubMed Web of Science ®Google Scholar
• Ying H, Kimmelman AC, Lyssiotis CA, et al. Oncogenic kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell. 2012;149(3):656–670.
   PubMed Web of Science ®Google Scholar
• Daemen A, Peterson D, Sahu N, et al. Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors. Proc Natl Acad Sci U S A. 2015;112(32):E4410–E4417.
   PubMed Web of Science ®Google Scholar
• Yang Y, Ishak Gabra MB, Hanse EA, et al. MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1. Nat Commun. 2019;10(1):809.
   PubMedGoogle Scholar
• Sun J, Zhang P, Yin T, et al. Upregulation of LncRNA PVT1 facilitates pancreatic ductal adenocarcinoma cell progression and glycolysis by regulating MiR-519d-3p and HIF-1A. J Cancer. 2020;11(9):2572–2579.
   PubMed Web of Science ®Google Scholar
• Tian G, Li G, Liu P, et al. Glycolysis-based genes associated with the clinical outcome of pancreatic ductal adenocarcinoma identified by the cancer genome atlas data analysis. DNA Cell Biol. 2020;39(3):417–427.
   PubMed Web of Science ®Google Scholar
• Guan H, Luo W, Liu Y, et al. Novel circular RNA circSLIT2 facilitates the aerobic glycolysis of pancreatic ductal adenocarcinoma via miR-510-5p/c-Myc/LDHA axis. Cell Death Dis. 2021;12(7):645.
   PubMed Web of Science ®Google Scholar
• Zeng Z, Zhao Y, Chen Q, et al. Hypoxic exosomal HIF-1α-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis . Oncogene. 2021;40(36):5505–5517.
   PubMed Web of Science ®Google Scholar
• Song B, Ji W, Guo S, et al. miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I. FEBS Lett. 2014;588(23):4375–4381.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yang H, Zhao L, et al. Circular RNA PRKCI promotes glioma cell progression by inhibiting microRNA-545. Cell Death Dis. 2019;10(8):616.
   PubMedGoogle Scholar
• Hu C, Wang Y, Li A, et al. Overexpressed circ_0067934 acts as an oncogene to facilitate cervical cancer progression via the miR-545/EIF3C axis. J Cell Physiol. 2019;234(6):9225–9232.
   PubMed Web of Science ®Google Scholar
• Bassi MT, Gasol E, Manzoni M, et al. Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc-. Pflugers Arch. 2001;442(2):286–296.
   PubMed Web of Science ®Google Scholar